MCK McKesson Corporation logo

MCK McKesson Corporation

Healthcare
$766.08-0.05%ClosedMarket Cap: $92.09B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

24.78

PEG

0.46

P/B

-43.07

P/S

0.23

EV/EBITDA

13.43

DCF Value

$1,232.00

FCF Yield

6.4%

Div Yield

0.4%

Margins & Returns

Gross Margin

3.6%

Operating Margin

1.6%

Net Margin

1.2%

ROE

-265.4%

ROA

5.8%

ROIC

31.1%

Financials

View All
PeriodRevenueNet IncomeEPS
Q4 null$96.30B$1.68B$
FY null$403.43B$4.76B$
Q3 null$106.16B$1.19B$
Q2 null$103.15B$1.11B$

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$994.86

Target (Median)

$970.00

Target Range

$875.00 - $1,085.00

4 Strong Buy11 Buy3 Hold0 Sell0 Strong Sell
CitigroupBuy
2026-05-14
Wells FargoEqual Weight
2026-05-12
Evercore ISI GroupOutperform
2026-05-08
JP MorganOverweight
2026-05-08
UBSBuy
2026-05-08

Trading Activity

Insider Trades

View All
Rutledge Napoleon B JRofficer: SVP, Controller & CAO
SellFri May 22
Rutledge Napoleon B JRofficer: SVP, Controller & CAO
SellFri May 22
Rodgers Thomas Lofficer: EVP, Chief Strategy & BDO
SellFri May 22
Lau Micheleofficer: EVP and Chief Legal Officer
SellFri May 22
Lau Micheleofficer: EVP and Chief Legal Officer
SellFri May 22

Congress Trades

View All
Lizzie FletcherSell
Fri May 01
Markwayne MullinBuy
Mon Mar 02

Company Info

Sector

Healthcare

Industry

Medical - Distribution

Country

US

Exchange

Beta

0.35

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.

Peers